Lien CE - Search Results

1

An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.

Torales J, Cuenca-Torres O, Barrios L, Armoa-Garcia L, Estigarribia G, Sanabria G, Lin MY, Antonio Estrada J, Estephan L, Cheng HY, Chen C, Janssen R, Lien CE. Torales J, et al. Among authors: lien ce. Vaccine. 2023 Jan 4;41(1):109-118. doi: 10.1016/j.vaccine.2022.10.030. Epub 2022 Nov 18. Vaccine. 2023. PMID: 36404171 Free PMC article. Clinical Trial.

2

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL. Lien CE, et al. Sci Rep. 2021 Apr 22;11(1):8761. doi: 10.1038/s41598-021-88283-8. Sci Rep. 2021. PMID: 33888840 Free PMC article.

3

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.

Hsieh SM, Liu MC, Chen YH, Lee WS, Hwang SJ, Cheng SH, Ko WC, Hwang KP, Wang NC, Lee YL, Lin YL, Shih SR, Huang CG, Liao CC, Liang JJ, Chang CS, Chen C, Lien CE, Tai IC, Lin TY. Hsieh SM, et al. Among authors: lien ce. Lancet Respir Med. 2021 Dec;9(12):1396-1406. doi: 10.1016/S2213-2600(21)00402-1. Epub 2021 Oct 13. Lancet Respir Med. 2021. PMID: 34655522 Free PMC article. Clinical Trial.

4

Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.

Lien CE, Kuo TY, Lin YJ, Lian WC, Lin MY, Liu LT, Cheng J, Chou YC, Chen C. Lien CE, et al. Clin Infect Dis. 2022 Jun 10;74(11):1899-1905. doi: 10.1093/cid/ciab711. Clin Infect Dis. 2022. PMID: 34739037 Free PMC article.

5

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.

Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, Buttigieg K, Carroll M, Charlton S, Lien CE, Lin MY, Chen CP, Cheng SH, Chen X, Lin TY, Fry EE, Ren J, Ma C, Townsend AR, Stuart DI. Huang KA, et al. Among authors: lien ce. Theranostics. 2022 Jan 1;12(1):1-17. doi: 10.7150/thno.65563. eCollection 2022. Theranostics. 2022. PMID: 34987630 Free PMC article.

6

Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.

Kuo TY, Lien CE, Lin YJ, Lin MY, Wu CC, Tang WH, Campbell JD, Traquina P, Chuang YS, Liu LT, Cheng J, Chen C. Kuo TY, et al. Among authors: lien ce. J Infect Dis. 2022 Nov 1;226(9):1562-1567. doi: 10.1093/infdis/jiac153. J Infect Dis. 2022. PMID: 35451470 Free PMC article.

7

Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study.

Hsieh SM, Chang SC, Cheng HY, Shih SR, Lien CE. Hsieh SM, et al. Among authors: lien ce. Infect Dis Ther. 2022 Aug;11(4):1493-1504. doi: 10.1007/s40121-022-00652-6. Epub 2022 May 17. Infect Dis Ther. 2022. PMID: 35579840 Free PMC article.

8

Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.

Lin YJ, Lin MY, Chuang YS, Liu LT, Kuo TY, Chen C, Ganesan S, Fattom A, Bitko V, Lien CE. Lin YJ, et al. Among authors: lien ce. Sci Rep. 2022 Jul 5;12(1):11369. doi: 10.1038/s41598-022-15238-y. Sci Rep. 2022. PMID: 35790783 Free PMC article.

9

Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial.

Waits A, Chen JY, Cheng WH, Yeh JI, Hsieh SM, Chen C, Janssen R, Lien CE, Lin TY. Waits A, et al. Among authors: lien ce. Int J Infect Dis. 2022 Nov;124:21-26. doi: 10.1016/j.ijid.2022.08.021. Epub 2022 Aug 29. Int J Infect Dis. 2022. PMID: 36049700 Free PMC article. Clinical Trial.

10

Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.

Ganesan S, Acosta H, Brigolin C, Orange K, Trabbic K, Chen C, Lien CE, Lin YJ, Lin MY, Chuang YS, Fattom A, Bitko V. Ganesan S, et al. Among authors: lien ce. PLoS One. 2022 Nov 2;17(11):e0272594. doi: 10.1371/journal.pone.0272594. eCollection 2022. PLoS One. 2022. PMID: 36322572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters